REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $213,000 | -6.2% | 6,432 | -7.5% | 0.00% | 0.0% |
| Q4 2021 | $227,000 | -30.2% | 6,950 | -10.3% | 0.00% | -33.3% |
| Q3 2021 | $325,000 | -74.3% | 7,750 | -76.2% | 0.00% | -72.7% |
| Q2 2021 | $1,263,000 | +6.3% | 32,500 | -6.7% | 0.01% | 0.0% |
| Q1 2021 | $1,188,000 | -35.9% | 34,833 | -14.7% | 0.01% | -45.0% |
| Q4 2020 | $1,852,000 | +55.6% | 40,825 | -5.6% | 0.02% | +33.3% |
| Q3 2020 | $1,190,000 | -16.2% | 43,241 | +12.2% | 0.02% | -21.1% |
| Q2 2020 | $1,420,000 | +18.2% | 38,551 | +4.0% | 0.02% | -9.5% |
| Q1 2020 | $1,201,000 | -18.3% | 37,080 | +3.3% | 0.02% | 0.0% |
| Q4 2019 | $1,470,000 | +30.6% | 35,886 | +13.4% | 0.02% | +16.7% |
| Q3 2019 | $1,126,000 | -22.9% | 31,642 | +11.2% | 0.02% | -14.3% |
| Q2 2019 | $1,461,000 | +106.1% | 28,450 | +129.9% | 0.02% | +90.9% |
| Q1 2019 | $709,000 | – | 12,375 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |